Clinical Trial Update: Dopaminergic Enhancement of Learning and Memory in Aphasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dopaminergic enhancement of learning and memory in aphasia following a cerebrovascular accident has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Snippet

Sponsor: University Hospital Muenster | Conditions: Cerebrovascular Accident, Aphasia | Phase 4 | Status: COMPLETED